Genital Diseases, Female  >>  matuzumab (EMD 72000)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
matuzumab (EMD 72000) / Takeda, EMD Serono
EMD 72000-030, NCT00073541: A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

Completed
2
38
US
EMD 72000
EMD Serono
Ovarian Cancer
03/04
08/04

Download Options